⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Celerion and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Celerion
↗Lincoln, Nebraska, USA
Celerion is a leading global Contract Research Organization (CRO) specializing in early-phase clinical research. The company provides end-to-end services including clinical trial design, patient recruitment, site management, bioanalytical testing, and regulatory affairs, primarily focusing on Phase I-IIb drug development.
With over 50 years of history, Celerion operates state-of-the-art clinical facilities across North America and Europe. They are known for their expertise in complex studies such as first-in-human dose escalation, cardiovascular safety, and drug-drug interactions, helping pharmaceutical and biotechnology clients accelerate the translation of scientific discoveries into actionable medical data.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Founded:1969
Ownership:private
Status:operating
FUNDING
Investors:H.I.G. Capital
PIPELINE
Stage:N/A
Lead Drug Stage:N/A
Modalities:Small molecule, Large molecule
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Pharmaceutical and biotechnology companies (global)
COMPETITION
Position:Leader
Competitors:Parexel International, IQVIA, Labcorp Drug Development, PPD (Thermo Fisher Scientific)
LEADERSHIP
Key Executives:
Susan Thornton - CEO
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Celerion. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.